Grace Expands Capacity by 25% in Michigan API Facility

• Grace announces expansion of its contract development and manufacturing (CDMO) facility in South Haven, Michigan.

• The expansion includes a new 4,000-gallon centrifuge and a trio of 4,000-gallon, multiuse chemical reactors.

W.R. Grace & Co has announced the opening of its expanded fine chemical contract development and manufacturing, increasing capacity by 25%.

The expansion will introduce a new 4,000-gallon multi-use reactor train, consisting of glass-lined and stainless-steel materials of construction¹. Additionally, a HASTELLOY centrifuge will be included to facilitate product isolation, greatly enhancing the commercial capability of the cGMP-compliant site.

“The additional capacity and cutting-edge equipment in South Haven bolster our ability to grow with our current and future customers through every stage of fine chemical manufacturing—from research and development, to clinical trials, scale-up services and commercial production of custom molecules and compounds,” Brenda Kelly, Grace’s president of materials technologies, said in the release.

“The newly expanded South Haven facility cements our position as a leading North American contract development and manufacturing organization (CDMO) and a leading employer in the community,” said Ed Sparks, Chief Executive Officer, Grace. “Equally important, the expansion solidifies our commitment to helping our fine chemical customers bring lifesaving and life-changing drug therapies to people everywhere.”